Claris Lifesciences moves up on selling its stake in JV to Otsuka Pharmaceutical Factory

21 Sep 2017 Evaluate

Claris Lifesciences is currently trading at Rs. 375.00, up by 1.75 points or 0.47% from its previous closing of Rs. 373.25 on the BSE.

The scrip opened at Rs. 373.90 and has touched a high and low of Rs. 383.90 and Rs. 372.00 respectively. So far 276362 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 430.10 on 16-Dec-2016 and a 52 week low of Rs. 221.50 on 29-Sep-2016.

Last one week high and low of the scrip stood at Rs. 383.90 and Rs. 369.30 respectively. The current market cap of the company is Rs. 2051.48 crore.

The promoters holding in the company stood at 50.13%, while Institutions and Non-Institutions held 28.08% and 21.79% respectively.

Claris Lifesciences has completed the sale of its remaining 20% stake in Otsuka Pharmaceutical India, the joint venture with Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co., to Otsuka Pharmaceutical Factory, Inc. (Japan) for a consideration of $20 million. The agreement to sell was announced on May 8, 2017.

Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology.

Peers
Company Name CMP
Redington 195.00
Adani Enterprises 2230.00
Amrapali Industries 18.14
Rashi Peripheral 371.10
Compuage Infocom 2.58
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.